• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MENTOR TEXAS ARTOURA BREAST TISSUE EXPANDER; EXPANDER, SKIN, INFLATABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MENTOR TEXAS ARTOURA BREAST TISSUE EXPANDER; EXPANDER, SKIN, INFLATABLE Back to Search Results
Catalog Number SMXP130RH
Medical Device Problem Code Material Rupture (1546)
Health Effect - Clinical Code No Code Available (3191)
Date of Event 10/11/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The mentor failure analysis lab has received the device for evaluation.The analysis has begun but is not complete at this time.When the investigational analysis has been completed, a supplemental report will be submitted.A manufacturing record evaluation (mre) was performed, and no anomalies were found related to this complaint.In addition, the mre verifies that the device was manufactured in accordance with documented specification and procedures.Reason for device explant and/or reoperation: deflation.Concomitant products: catalog smxp130rh , an artoura breast tissue expander 475cc, catalog number left lot 7709041.Manufacturer¿s reference number: (b)(4).
 
Event or Problem Description
It was reported that a (b)(6) year old female patient underwent a breast reconstruction with an artoura breast tissue expander 475cc and experienced deflation on the right breast tissue expander.As a result, the patient had undergone removal and replacement with unspecified implant on (b)(6) 2019.
 
Additional Manufacturer Narrative
On 12/11/2019, the visual analysis of the device showed there was a tear in one of the suture tab, on inferior location, measuring approximately 0.5 cm.Microscopic examination was performed to the rupture and no evidence of instrument damage was observed.No additional anomalies were observed.The second product received is related to a concomitant device, there are neither deficiencies alleged nor patient injuries.Therefore, no further investigation is required.The manufacturing records were reviewed, and the manufacturing criteria were met prior to the release of this lot.It should be noted that as part of our quality process, each device is visually inspected during manufacturing to ensure the device meets the required specifications prior to shipment.Although the manufacturing criteria was met during manufacturing, there is an open investigation to address with the defects of the suture tabs on the tissue expander as seen by the customer.Manufacturer¿s reference number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARTOURA BREAST TISSUE EXPANDER
Common Device Name
EXPANDER, SKIN, INFLATABLE
Manufacturer (Section D)
MENTOR TEXAS
3041 skyway circle north
irving TX 75038
MDR Report Key9271660
Report Number1645337-2019-23031
Device Sequence Number160608
Product Code LCJ
UDI-Device Identifier00081317024316
UDI-Public00081317024316
Combination Product (Y/N)N
Initial Reporter StateKY
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Device Explanted Year2019
Reporter Type Manufacturer
Report Source health professional
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 10/14/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date06/26/2023
Device Catalogue NumberSMXP130RH
Device Lot Number7743000
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/22/2019
Initial Date Received by Manufacturer 10/14/2019
Supplement Date Received by Manufacturer12/11/2019
Initial Report FDA Received Date11/04/2019
Supplement Report FDA Received Date12/12/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age37 YR
-
-